Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#oncology—Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, announced today the appointment…
DUBLIN–(BUSINESS WIRE)–The “Small Molecule API Contract Manufacturer Quality Benchmarking (5th Edition)” report has been added to ResearchAndMarkets.com’s offering. Small Molecule…
DUBLIN–(BUSINESS WIRE)–The “Advanced Pharmacovigilance” conference has been added to ResearchAndMarkets.com’s offering. This course will be of maximum benefit to those…
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) being developed to treat infected, high-risk individuals with COVID-19 Exploring the potential to repurpose marketed…
– Reports audited financial results for the Fourth Quarter and Full Year ended December 31, 2019 – TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma…
LYON, France–(BUSINESS WIRE)–POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for…
With No Approved Treatments in Rett Syndrome, FDA Decision Highlights Significant Unmet Need SAN DIEGO & MELBOURNE, Australia–(BUSINESS WIRE)–ACADIA Pharmaceuticals…
Nation’s largest HIV/AIDS organization files brief of amicus curiae with the U.S. Supreme Court in Rutledge v. Pharmaceutical Care Management…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology pioneer focused on innovative aesthetic and therapeutic offerings, including its next-generation…